Doximity Shares Slide After Outlook Miss Signals Slowing Growth
Doximity shares fell after the company's outlook missed expectations and indicated slowing sales growth.
Shares sank 22% to $45.8 in overnight trading.
The networking platform for healthcare professionals said it expects revenue for the current quarter to be $139 million to $140 million. Analysts polled by FactSet were projecting $143.3 million.
The company's full-year revenue outlook was $619 million to $631 million, also below the $634.6 million Wall Street was forecasting.
The expected full-year revenue would mark a leveling off of growth. Doximity's sales rose 20% in 2025 to $570.4 million. The midpoint of Doximity's full-year guidance would be a roughly 9.6% growth in revenue year-over-year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10